Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?

Manifold·Science and Technology

As of 16:05 UTC on 29 Oct 2026, Manifold prices “Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?” at 80%. The market has no Manifold-reported volume in the last 24 hours. pdata.world compares it with 24 related events on Polymarket, Manifold and Kalshi.

I will defer resolution value to reputable news organizations